cutr20200806_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 


CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

August 6, 2020

 

 

Date of Report (date of earliest event reported)

 

 


Cutera, Inc.

(Exact name of Registrant as specified in its charter)

 


 

 

Delaware

 

000-50644

 

77-0492262

(State or other jurisdiction of

incorporation or organization)

 

(Commission File Number)

 

(I.R.S. Employer

Identification Number)

 

3240 Bayshore Blvd.

Brisbane, California 94005

(Address of principal executive offices)

 

(415) 657-5500

(Registrant’s telephone number, including area code)

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock ($0.001 par value)

CUTR

The NASDAQ Stock Market, LLC

 

 

N/A

(Former name or former address, if changed since last report)

 

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company   ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 2.02.

Results of Operations and Financial Condition.

 

On August 6, 2020, Cutera, Inc. (“Cutera” or the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2020. Cutera hereby incorporates by reference herein the information set forth in its press release dated August 6, 2020, a copy of which is attached hereto as Exhibit 99.1. Except as otherwise provided in the press release, the press release speaks only as of the date of such press release and it shall not create any implication that the affairs of Cutera have continued unchanged since such date.

 

The Company will host a live audio webcast for interested parties commencing Thursday, August 6, 2020 at 1:30 p.m. PDT (4:30 p.m. EDT), during which the Company will discuss the financial results. The conference call will be available to interested parties through a live audio webcast and accessible through the Investor Relations section of the Cutera corporate website at www.cutera.com.

 

The information provided pursuant to this Item 2.02 is to be considered “furnished” pursuant to Item 2.02 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed incorporated by reference into any of Cutera’s reports or filings with the Securities and Exchange Commission, whether made before or after the date hereof, except as expressly set forth by specific reference in such report or filing.

 

Except for the historical information contained in this report, the statements made by Cutera are forward-looking statements that involve risks and uncertainties. All such statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Cutera’s future financial performance could differ significantly from the expectations of management and from results expressed or implied in the press release. Please refer to the last paragraph of the text portion of the press release for further discussion about forward-looking statements. For further information on risk factors, please refer to “Risk Factors” contained in Cutera’s most recently filed Form 10-K and its subsequent filings with the Securities and Exchange Commission, as well as in the press release attached as Exhibit 99.1 hereto. Cutera disclaims any obligation or duty to update or modify these forward-looking statements.

 

 

 

Item 9.01.

Financial Statements and Exhibits.

 

(d)

Exhibits.

 

     

Exhibit No.

  

Description

   

99.1

  

Press Release of Cutera, Inc. dated as of August 6, 2020.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

         
 

 

 

 

CUTERA, INC.

     

Date: August 6, 2020

 

 

 

 /s/ DARREN W. ALCH

 

 

 

 

Darren W. Alch

 

 

 

 

General Counsel & Corporate Secretary

 

 

 
ex_197739.htm

Exhibit 99.1

 

 

 

Cutera, Inc. Announces Second Quarter 2020 Financial Results

 

BRISBANE, California, August 6, 2020 ─ Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the second quarter ended June 30, 2020.

 

Second Quarter 2020 Financial and Operational Highlights

 

Revenue was $26.4 million, a 45% decrease from the prior-year period, as COVID-19 disruptions led to a year-over-year decline in procedures during the quarter

 

o

Capital Equipment revenue of $15.5 million, a decline of 59% over prior-year period

 

o

Recurring revenue grew 6% over prior-year period driven primarily by Skin Care revenue growth of 169% year-over-year offsetting declines in Service and Consumables revenue

 

Gross Margin was 44%, compared to 54% in the prior-year period, driven by lower production levels and substantially lower overhead absorption during the quarter, partially offset by strong pricing discipline and a reduction in manufacturing headcount

Net loss was $11.4 million, or $0.67 per fully diluted share, as compared to a net income of $0.6 million, or $0.04 per fully diluted share, in the prior-year period

Closed a public stock offering on April 21, 2020, resulting in approximately $26.5 million in net proceeds

Subsequent to the quarter, the Company secured a $30 million credit facility with Silicon Valley Bank, replacing the Company’s existing $25 million facility with Wells Fargo

 

“While our second quarter results were impacted by a decline in patient volumes associated with COVID-related shutdowns; I am encouraged by the recovery trends as patient volumes continue to rebound toward pre-COVID levels,” commented Dave Mowry, Chief Executive Officer of Cutera, Inc. “I am pleased with our increased customer outreach efforts which we implemented during the quarter, leading to improved customer engagement and enabled us to be highly responsive, helping accounts increase their patient traffic. I am amazed by the resilience and adaptability of our customers, and proud of the Cutera team’s work to steer the company and our clients through unprecedented adversity. We are continuing to manage the impacts of the pandemic effectively, and, with a recently strengthened balance sheet, we are well-positioned to drive a continued recovery in our business through the second half of the year despite the uncertain environment.”

 

 

 

2020 Financial Outlook

As previously announced on April 3, 2020, Cutera has withdrawn its previously announced full-year 2020 guidance due to uncertainty over the magnitude and duration of the impacts from the COVID-19 pandemic on its financial results. The Company will not be providing updated guidance at this time.

 

Conference Call

The Company’s management will host a conference call to the discuss these results and related matters today at 1:30 p.m. PT (4:30 p.m. ET) that same day. Participating on the call will be Dave Mowry, Chief Executive Officer, Jason Richey, President, and Fuad Ahmad, Interim Chief Financial Officer.

 

To participate in the conference call, dial 1-877-705-6003 (domestic) or + 1-201-493-6725 (international) and refer to the Conference Code: 13706585.

 

The call will also be webcast and can be accessed from the Investor Relations section of Cutera’s website at http://www.cutera.com/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

 

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has developed innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

 

 

 

*Use of Non-GAAP Financial Measures

 

In this press release, in order to supplement the Company’s condensed consolidated financial statements presented in accordance with Generally Accepted Accounting Principles, or GAAP, management has disclosed certain non-GAAP financial measures for the statement of operations and net income (loss) per diluted share. Non-GAAP adjustments include stock-based compensation, depreciation, amortization, executive and other non-recurring separation costs, customer relationship management (“CRM”) and enterprise resource planning (“ERP”) system costs, non-recurring legal and litigation costs, as well as the net tax impact of excluding these items. From time to time in the future, there may be other items that we may exclude if the Company believes that doing so is consistent with the goal of providing useful information to investors and management. The Company has provided a reconciliation of each non-GAAP financial measure used in this earnings release to the most directly comparable GAAP financial measure. The Company has not provided a reconciliation of non-GAAP guidance measures to the corresponding GAAP measures on a forward-looking basis due to the potential significant variability, limited visibility, unpredictability, or unique non-recurring nature of the items. Forward-looking non-GAAP measures include adjusted EBITDA. The Company defines adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, stock-based compensation, executive and other non-recurring separation costs, customer relationship management (“CRM”) and enterprise resource planning (“ERP”) system costs, and non-recurring legal and litigation costs.

 

Company management uses these measurements as aids in monitoring the Company’s ongoing financial performance from quarter to quarter, and year to year, on a regular basis and for benchmarking against other similar companies. Non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. These non-GAAP financial measures should be considered along with, but not as alternatives to, the operating performance measure as prescribed by GAAP. Non-GAAP financial measures for the statement of operations and net income per diluted share exclude the following:

 

Non-cash expenses for stock-based compensation. The Company has excluded the effect of stock-based compensation expenses in calculating its non-GAAP operating expenses and net income measures. Although stock-based compensation is a key incentive offered to its employees, the Company continues to evaluate its business performance excluding stock-based compensation expenses. The Company records stock-based compensation expense related to grants of options, employee stock purchase plan, and performance and restricted stock. Depending upon the size, timing and the terms of the grants, this expense may vary significantly but will recur in future periods. The Company believes that excluding stock-based compensation better allows for comparisons to its peer companies;

 

 

 

Depreciation and amortization. The Company has excluded depreciation and amortization expense in calculating its non-GAAP operating expenses and net income measures. Depreciation and amortization are non-cash charges to current operations;

 

Executive and other non-recurring separation costs. We have excluded costs associated with the resignation of our former Executive Officers in calculating our non-GAAP operating expenses and net income measures. We exclude these and other non-recurring employee separation costs because we believe that these items do not reflect future operating expenses;

 

Customer Relationship Management. We have excluded CRM system costs related to direct and incremental costs incurred in connection with our multi-phase implementation of a new CRM solution and the related technology infrastructure costs. We exclude these costs because we believe that these items do not reflect future operating expenses and will be inconsistent in amounts and frequency making it difficult to contribute to a meaningful evaluation of our operating performance; and

 

Enterprise Resource Planning. We have excluded ERP system costs related to direct and incremental costs incurred in connection with our multi-phase implementation of a new ERP solution and the related technology infrastructure costs. We exclude these costs because we believe that these items do not reflect future operating expenses and will be inconsistent in amounts and frequency making it difficult to contribute to a meaningful evaluation of our operating performance.

 

Non-recurring legal and litigation costs. We have excluded costs incurred related to third party litigation and disputes, that are of a non-recurring nature.

 

The Company believes that excluding all of the items above allows users of its financial statements to better review and assess both current and historical results of operations.

 

 

 

Safe Harbor Statement

Certain statements in this press release, other than purely historical information, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements include, but are not limited to, Cutera’s plans, objectives, strategies, financial performance and outlook, CFO and other senior leadership searches, product launches and performance, trends, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, the Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “seek,” “guidance,” “predict,” “potential,” “likely,” “believe,” “will,” “should,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “forecast,” “foresee” or variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond the Company’s control, that could cause its actual results to differ materially from the forward-looking statements contained in this press release, including those described in the “Risk Factors” section of Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, the Registration Statement on Form S-,8 and other documents filed from time to time with the United States Securities and Exchange Commission by Cutera.

 

All information in this press release is as of the date of its release. Accordingly, undue reliance should not be placed on forward-looking statements. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. If the Company updates one or more forward-looking statements, no inference should be drawn that it will make additional updates with respect to those or other forward-looking statements. Cutera's financial performance for the second quarter ended June 30, 2020, as discussed in this release, is preliminary and unaudited, and subject to adjustment.

 

 

 

 

Cutera, Inc.

Anne Werdan

Director, Investor Relations

415-657-5500

awerdan@cutera.com 

 

 

 

CUTERA, INC. 

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands) 

(unaudited) 

 

   

June 30,

   

March 31,

   

December 31,

 
   

2020

   

2020

   

2019

 

Assets

                       

Current assets:

                       

Cash and cash equivalents

  $ 33,659     $ 14,774     $ 26,316  

Marketable investments

    12,894       4,746       7,605  

Accounts receivable, net

    13,826       15,660       21,556  

Inventories

    31,240       36,941       33,921  

Other current assets and prepaid expenses

    5,313       4,831       5,648  

Total current assets

    96,932       76,952       95,046  
                         

Property and equipment, net

    2,417       2,687       2,817  

Deferred tax asset

    419       408       423  

Goodwill

    1,339       1,339       1,339  

Operating lease right-of-use assets

    7,577       7,143       7,702  

Other long-term assets

    4,733       5,901       6,411  

Total assets

  $ 113,417     $ 94,430     $ 113,738  
                         

Liabilities and Stockholders' Equity

                       

Current liabilities:

                       

Accounts payable

  $ 11,681     $ 14,604     $ 12,685  

Accrued liabilities

    20,423       23,663       30,307  

Operating leases liabilities

    1,526       2,204       2,800  

Extended warranty liabilities

    1,660       1,765       1,999  

Deferred revenue

    9,345       10,180       10,831  

Total current liabilities

    44,635       52,416       58,622  
                         

Deferred revenue, net of current portion

    2,434       2,789       3,391  

Income tax liability

    93       93       93  

Long-Term Debt

    7,149       -       -  

Operating lease liabilities, net of current portion

    6,262       5,149       5,112  

Other long-term liabilities

    345       447       578  

Total liabilities

    60,918       60,894       67,796  
                         

Stockholders’ equity:

                       

Common stock

    18       15       14  

Additional paid-in capital

    112,644       82,292       82,346  

Accumulated deficit

    (60,166 )     (48,772 )     (36,358 )

Accumulated other comprehensive loss

    3       1       (60 )

Total stockholders' equity

    52,499       33,536       45,942  

Total liabilities and stockholders' equity

  $ 113,417     $ 94,430     $ 113,738  

 

 

 

CUTERA, INC. 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited) 

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

   

June 30,

   

June 30,

 
   

2020

   

2019

   

2020

   

2019

 
                                 

Products

  $ 21,745       41,968       48,136     $ 72,730  

Service

    4,624       5,806       10,472       11,070  

Total net revenue

    26,369       47,774       58,608       83,800  
                                 

Products

    12,206       18,393       26,309       33,935  

Service

    2,539       3,550       6,339       6,725  

Total cost of revenue

    14,745       21,943       32,648       40,660  

Gross profit

    11,624       25,831       25,960       43,140  

Gross margin %

    44 %     54 %     44 %     51 %
                                 

Operating expenses:

                               

Sales and marketing

    11,035       16,992       25,823       33,096  

Research and development

    2,991       3,273       6,862       6,979  

General and administrative

    8,529       5,267       16,336       10,792  

Total operating expenses

    22,555       25,532       49,021       50,867  

Income (loss) from operations

    (10,931 )     299       (23,061 )     (7,727 )

Interest and other income (expense), net

    3       46       (204 )     (33 )

Income (loss) before income taxes

    (10,928 )     345       (23,265 )     (7,760 )

Income tax benefit

    466       (243 )     543       (128 )

Net income (loss)

  $ (11,394 )   $ 588     $ (23,808 )   $ (7,632 )
                                 

Net income (loss) per share:

                               

Basic

  $ (0.67 )   $ 0.04     $ (1.51 )   $ (0.54 )

Diluted

  $ (0.67 )   $ 0.04     $ (1.51 )   $ (0.54 )
                                 

Weighted-average number of shares used in per share calculations:

                               

Basic

    17,055       14,086       15,744       14,051  

Diluted

    17,055       14,356       15,744       14,051  

 

 

 

CUTERA, INC.

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in thousands, except percentage data)

(unaudited)

 

 

   

Three Months Ended

   

% Change

   

Six Months Ended

   

% Change

 
   

June 30,

   

June 30,

   

2020 Vs

   

June 30,

   

June 30,

   

2020 Vs

 
   

2020

   

2019

   

2019

   

2020

   

2019

   

2019

 

Revenue By Geography:

                                               

United States

  $ 10,915     $ 28,147       -61 %   $ 24,699     $ 48,547       -49 %

International

    15,454       19,627       -21 %     33,909       35,253       -4 %

Total Net Revenue

  $ 26,369     $ 47,774       -45 %   $ 58,608     $ 83,800       -30 %

International as a percentage of total revenue

    59 %     41 %             58 %     42 %        
                                                 

Revenue By Product Category:

                                               

Systems

                                               

- North America

  $ 8,214     $ 26,491       -69 %   $ 18,596     $ 44,071       -58 %

- Rest of World

    7,328       11,048       -34 %     17,904       20,677       -13 %

Total Systems

    15,542       37,539       -59 %     36,500       64,748       -44 %

Consumables

    1,425       2,654       -46 %     3,958       4,599       -14 %

Skincare

    4,778       1,775    

+169%

      7,678       3,383    

+127%

 

Total Products

    21,745       41,968       -48 %     48,136       72,730       -34 %
                                                 

Service

    4,624       5,806       -20 %     10,472       11,070       -5 %

Total Net Revenue

  $ 26,369     $ 47,774       -45 %   $ 58,608     $ 83,800       -30 %

 


 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

   

June 30,

   

June 30,

 
   

2020

   

2019

   

2020

   

2019

 

Pre-tax Stock-Based Compensation Expense:

                               

Cost of revenue

  $ 743     $ 404     $ 1,033     $ 673  

Sales and marketing

    1,251       997       1,969       1715  

Research and development

    769       370       1,090       633  

General and administrative

    1,332       748       1,982       805  
    $ 4,095     $ 2,519     $ 6,075     $ 3,826  

 

 

 

CUTERA, INC. 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands) 

(unaudited) 

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

   

June 30,

   

June 30,

 
   

2020

   

2019

   

2020

   

2019

 

Cash flows from operating activities:

                    -          

Net income (loss)

  $ (11,394 )   $ 588     $ (23,808 )   $ (7,632 )

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

                               

Stock-based compensation

    4,095       2,519       6,075       3,826  

Depreciation of tangible assets

    355       404       715       815  

Amortization of contract acquisition costs

    675       722       1,392       1,412  

Impairment of cloud computing costs

    805       -       805       -  

Change in deferred tax asset

    (11 )     (7 )     4       (1 )

Provision for doubtful accounts receivable

    1,106       (117 )     1,696       (19 )

Other

    163       48       198       151  

Changes in assets and liabilities:

    -                          

Accounts receivable

    728       (5,666 )     6,034       (5,263 )

Inventories

    5,701       (230 )     2,681       1,125  

Other current assets and prepaid expenses

    (491 )     302       316       (614 )

Other long-term assets

    (312 )     (1,073 )     (519 )     (1,752 )

Accounts payable

    (2,923 )     1,104       (1,004 )     162  

Accrued liabilities

    (3,187 )     5,246       (9,754 )     3,779  

Extended warranty liabilities

    (105 )     (268 )     (339 )     (760 )

PPP Loan Payable

    -               -          

Other long-term liabilities

    -       -       -       (140 )

Deferred revenue

    (1,190 )     768       (2,443 )     1,293  

Income tax liability

    -       (306 )     -       (301 )

Net cash provided by (used in) operating activities

    (5,985 )     4,034       (17,951 )     (3,919 )
                                 

Cash flows from investing activities:

                               

Acquisition of property, equipment and software

    (205 )     (251 )     (435 )     (316 )

Disposal of Property and equipment

    -       20       -       20  

Proceeds from maturities of marketable investments

    4,100       6,400       10,900       9,600  

Purchase of marketable investments

    (12,237 )     (2,434 )     (16,167 )     (4,020 )

Net cash provided by (used in) investing activities

    (8,342 )     3,735       (5,702 )     5,284  
                                 

Cash flows from financing activities:

                               

Proceeds from exercise of stock options and employee stock purchase plan

    647       1,032       848       1,163  

Proceeds from PPP Loan

    7,149               7,149          

Proceeds from equity offering

    26,496       -       26,496       -  

Taxes paid related to net share settlement of equity awards

    (883 )     (80 )     (3,117 )     (570 )

Payments on finance lease obligations

    (197 )     (211 )     (380 )     (342 )

Net cash provided by financing activities

    33,212       741       30,996       251  
                                 

Net increase in cash and cash equivalents

    18,885       8,510       7,343       1,616  

Cash and cash equivalents at beginning of period

    14,774       19,158       26,316       26,052  

Cash and cash equivalents at end of period

  $ 33,659     $ 27,668     $ 33,659     $ 27,668  

 

 

 

CUTERA, INC. 

RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

TO  NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited) 

 

 

Three Months Ended June 30, 2020

 

Three Months Ended June 30, 2019

 
 

GAAP

 

Depreciation
and
Amortization

 

Stock-Based
Compensation

 

CRM and ERP
Implementation/ write-off

 

Severance (RIF)

 

Legal -Former CFO Settlement/Lutronic

 

Taxes and
Other Adjustments

 

Non-GAAP

 

GAAP

 

Depreciation
and
Amortization

 

Stock-Based
Compensation

 

CRM and ERP
Implementation

 

Taxes and
Other Adjustments

 

Non-GAAP

 
                                                                 

Net revenue

$ 26,369   -   -   -           -   $ 26,369   $ 47,774   -   -       -   $ 47,774  

Cost of revenue

  14,745   (136 ) (743 ) -           -     13,866     21,943   (123 ) (404 )     -     21,416  

Gross profit

  11,624   136   743   -           -     12,503     25,831   123   404       -     26,358  

Gross margin %

  44 %                           47 %   54 %                   55 %
                                                                 

Operating expenses:

                                                               

Sales and marketing

  11,035   (827 ) (1,251 ) -           -     8,957     16,992   (912 ) (997 ) (27 ) -     15,056  

Research and development

  2,991   (38 ) (769 ) -           -     2,184     3,273   (26 ) (370 ) -   -     2,877  

General and administrative

  8,529   (29 ) (1,332 ) (729 ) (518 ) (1,018 ) -     4,903     5,267   (65 ) (748 ) (460 ) -     3,994  

Total operating expenses

  22,555   (894 ) (3,352 ) (729 ) (518 ) (1,018 ) -     16,044     25,532   (1,003 ) (2,115 ) (487 ) -     21,927  

Income (loss) from operations

  (10,931 ) 1,030   4,095   729   518   1,018   -     (3,541 )   299   1,126   2,519   487   -     4,431  

Interest and other income (expense), net

  3   -   -   -   -   -   -     3     46   -   -   -   -     46  

Loss before income taxes

  (10,928 ) 1,030   4,095   729   518   1,018   -     (3,538 )   345   1,126   2,519   487   -     4,477  

Provision (benefit) for income taxes

  466   -   -   -   -   -   (3 )   463     (243 ) -   -   -   (397 )   (640 )

Net income (loss)

$ (11,394 ) 1,030   4,095   729   518   1,018   3   $ (4,001 ) $ 588   1,126   2,519   487   397   $ 5,117  
                                                                 

Net income (loss) per share:

                                                               

Basic

$ (0.67 )                         $ (0.23 ) $ 0.04                   $ 0.36  

Diluted

$ (0.67 )                         $ (0.23 ) $ 0.04                   $ 0.36  
                                                                 

Weighted-average number of shares used in per share calculations:

                                                               

Basic

  17,055                             17,055     14,086                     14,086  

Diluted

  17,055                             17,055     14,356                     14,311  

 

 

Operating expenses as a % of net revenue

 

GAAP

   

Non-GAAP

   

GAAP

   

Non-GAAP

 

Sales and marketing

    41.8 %     34.0 %     35.6 %     31.5 %

Research and development

    11.3 %     8.3 %     6.9 %     6.0 %

General and administrative

    32.3 %     18.6 %     11.0 %     8.4 %
      85.5 %     60.8 %     53.4 %     45.9 %

 

 

CUTERA, INC. 

RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

TO  NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited) 

 

 

Six Months Ended June 30, 2020

 

Six Months Ended June 30, 2019

 
 

GAAP

 

Depreciation
and
Amortization

 

Stock-Based
Compensation

 

CRM and ERP
Implementation/ write-off

 

Severance (RIF)

 

Legal -Former CFO Settlement/Lutronic

 

Taxes and
Other Adjustments

 

Non-GAAP

 

GAAP

 

Depreciation
and
Amortization

 

Stock-Based
Compensation

 

CRM and ERP
Implementation

 

Taxes and
Other Adjustments

 

Non-GAAP

 
                                                                 

Net revenue

$ 58,608   -   -   -   -   -   -   $ 58,608   $ 83,800   -   -       -   $ 83,800  

Cost of revenue

  32,648   (277 ) (1,033 ) -   -   -   -     31,338     40,660   (251 ) (673 )     -     39,736  

Gross profit

  25,960   277   1,033   -   -   -   -     27,270     43,140   251   673       -     44,064  

Gross margin %

  44 %                           47 %   51 %                   53 %
                                                                 

Operating expenses:

                                                               

Sales and marketing

  25,823   (1,698 ) (1,969 ) -   -   -   -     22,156     33,096   (1,783 ) (1,715 ) (112 ) -     29,486  

Research and development

  6,862   (76 ) (1,090 ) -   -   -   -     5,696     6,979   (46 ) (633 ) -   -     6,300  

General and administrative

  16,336   (56 ) (1,982 ) (729 ) (518 ) (1,018 ) -     9,387     10,792   (147 ) (805 ) (699 ) (614 ) (a)   8,526  

Total operating expenses

  49,021   (1,830 ) (5,042 ) (729 ) (518 ) (1,018 ) -     37,238     50,867   (1,976 ) (3,153 ) (811 ) (614 )   44,313  

Loss from operations

  (23,061 ) 2,107   5,042   729   518   1,018   -     (9,968 )   (7,727 ) 2,227   3,826   811   614     (249 )

Interest and other income (expense), net

  (204 ) -   -   -   -   -   -     (204 )   (33 ) -   -   -   -     (33 )

Loss before income taxes

  (23,265 ) 2,107   5,042   729   518   1,018   -     (10,172 )   (7,760 ) 2,227   3,826   811   614     (282 )

Provision (benefit) for income taxes

  543   -   -   -   -   -   2     545     (128 ) -   -   -   282     154  

Net income (loss)

$ (23,808 ) 2,107   5,042   729   518   1,018   (2 ) $ (10,717 ) $ (7,632 ) 2,227   3,826   811   332   $ (436 )
                                                                 

Net income (loss) per share:

                                                               

Basic

$ (1.51 )                         $ (0.68 ) $ (0.54 )                 $ (0.03 )

Diluted

$ (1.51 )                         $ (0.68 ) $ (0.54 )                 $ (0.03 )
                                                                 

Weighted-average number of shares used in per share calculations:

                                                               

Basic

  15,744                             15,744     14,051                     14,051  

Diluted

  15,744                             15,744     14,051                     14,298  

 

a) Other adjustment of $614 related to Executive separation costs.

 

 

Operating expenses as a % of net revenue

 

GAAP

   

Non-GAAP

   

GAAP

   

Non-GAAP

 

Sales and marketing

    44.1 %     37.8 %     39.5 %     35.2 %

Research and development

    11.7 %     9.7 %     8.3 %     7.5 %

General and administrative

    27.9 %     16.0 %     12.9 %     10.2 %
      83.6 %     63.5 %     60.7 %     52.9 %

 

 

 

CUTERA, INC. 

RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA

(in thousands)

(unaudited) 

 

   

Three Months

Ended

   

Six Months

Ended

 
    June 30, 2020  

Net loss

  $ (11,394 )   $ (23,808 )

Adjustments:

               

Stock-based compensation

    4,095       6,075  

Depreciation and amortization

    1,030       2,107  

CRM and ERP Implementation/write-off

    729       1,139  

Severance (RIF)

    518       518  

Taxes and Other Adjustments

    -       324  

Legal -Former CFO Settlement/Lutronic

    1,018       1,018  

Interest and other (income) expense, net

    (3 )     204  

Benefit for income taxes

    466       543  

Total adjustments

  $ 7,853     $ 11,928  
                 

Adjusted EBITDA

  $ (3,541 )   $ (11,880 )